Literature DB >> 10222432

Control of proliferation and survival of C6 glioma cells with modification of the nerve growth factor autocrine system.

T Watanabe1, Y Katayama, S Kimura, A Yoshino.   

Abstract

Nerve growth factor (NGF) plays an important physiological role in differentiation and survival of various types of neurons. Glial cells and glial tumor cells synthesize multiple neurotrophic factors including NGF and secrete them into the surrounding environment; however, the mechanisms of NGF and the significance of NGF receptors have not been studied in detail. The C6 glioma cell line can synthesize NGF, respond to exogenous application of NGF and stimulate the expression of NGF receptor in an autocrine manner. In order to determine the significance of such an NGF autocrine system, the effects of exposure to exogenous NGF and deprivation of endogenous NGF were examined in a C6 glioma cell line in vitro. Exogenous NGF significantly inhibited maintenance of the cell number and thymidine incorporation. Morphological changes, including the formation of growth cones, outgrowth of processes and cellular hypertrophy, were observed, concurrently, indicating that exogenous NGF stimulated differentiation and thereby inhibited proliferation of the cells. Deprivation of endogenous NGF with anti-NGF antibody elicited a rapid decrease in cell number and thymidine incorporation, and led almost all of the cells to death within 8 days. The protein synthesis inhibitor, cycloheximide, strongly inhibited the death of NGF-deprived cells, suggesting the involvement of an active process requiring synthesis of suicide proteins. These findings imply that the NGF autocrine system plays a significant role in regulating the differentiation and survival of C6 glioma cells, similarly to neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222432     DOI: 10.1023/a:1006127624487

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.

Authors:  D R Kaplan; B L Hempstead; D Martin-Zanca; M V Chao; L F Parada
Journal:  Science       Date:  1991-04-26       Impact factor: 47.728

2.  Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor.

Authors:  W L Lowe; T Meyer; C W Karpen; L R Lorentzen
Journal:  Endocrinology       Date:  1992-05       Impact factor: 4.736

3.  Ontogeny of the nerve growth factor receptor in primary cultures of neural crest cells.

Authors:  C A Greiner; A T Lloyd; G Guroff
Journal:  Brain Res       Date:  1986-04       Impact factor: 3.252

4.  Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells.

Authors:  X N Li; Z W Du; Q Huang; J Q Wu
Journal:  Neurosurgery       Date:  1997-06       Impact factor: 4.654

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Modulation effects of hexamethylene bisacetamide on growth and differentiation of cultured human malignant glioma cells.

Authors:  X N Li; Z W Du; Q Huang
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

Review 7.  The changing scene of neurotrophic factors.

Authors:  H Thoenen
Journal:  Trends Neurosci       Date:  1991-05       Impact factor: 13.837

8.  Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

Authors:  A H Ross; P Grob; M Bothwell; D E Elder; C S Ernst; N Marano; B F Ghrist; C C Slemp; M Herlyn; B Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Cytoskeletal reorganization induced by nerve growth factor and glia maturation factor in anaplastic glioma cells.

Authors:  Y Marushige; K Marushige; D L Okazaki; A Koestner
Journal:  Anticancer Res       Date:  1989 Jul-Aug       Impact factor: 2.480

10.  Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells.

Authors:  S Kumar; J Huber; L A Peña; J R Perez-Polo; K Werrbach-Perez; J de Vellis
Journal:  J Neurosci Res       Date:  1990-11       Impact factor: 4.164

View more
  5 in total

1.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

2.  Nerve growth factor plays a divergent role in mediating growth of rat C6 glioma cells via binding to the p75 neurotrophin receptor.

Authors:  Carla Weis; Bettina Wiesenhofer; Christian Humpel
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

3.  Growth control of C6 glioma in vivo by nerve growth factor.

Authors:  Shigeyoshi Kimura; Atsuo Yoshino; Yoichi Katayama; Takao Watanabe; Takao Fukushima
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

4.  Expression of cannabinoid receptors and neurotrophins in human gliomas.

Authors:  C Calatozzolo; A Salmaggi; B Pollo; F L Sciacca; M Lorenzetti; A Franzini; A Boiardi; G Broggi; C Marras
Journal:  Neurol Sci       Date:  2008-01-04       Impact factor: 3.307

5.  In Vitro Evaluation of the Cytotoxic Effect of Streptococcus pyogenes Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line.

Authors:  Alexandr N Chernov; Anna Tsapieva; Diana A Alaverdian; Tatiana A Filatenkova; Elvira S Galimova; Mariia Suvorova; Olga V Shamova; Alexander N Suvorov
Journal:  Molecules       Date:  2022-01-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.